Vitek 2 and Vitek 2 Compact GN22 Antimicrobial Susceptibility Tests PRG0028/B2898 GN22 Development and Clinical Trial Protocol BMX.1.020042
T
Thomas E. Davis
Primary Investigator
Not Recruiting
100 years or below
All
Phase
N/A
1 Location
Brief description of study
The purpose of this study is to collect clinical isolate card and reference data to demonstrate the effectiveness of the GN22 card for antimicrobial testing when used on the Vitek2 and Vitek2 compact systems.
Detailed description of study
The purpose of this study is to collect clinical isolate card and reference data to demonstrate the effectiveness of the GN22 card for antimicrobial testing when used on the Vitek2 and Vitek2 compact systems.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: bacterial infection,1806874773
-
Age: 100 years or below
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 1806874773
